Medartis Overview
- Year Founded
-
1997
- Status
-
Public
- Employees
-
1,428
- Stock Symbol
-
MED
- Investments
-
10
- Share Price
-
$135.25
- (As of Friday Closing)
Medartis General Information
Description
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from Europe, Middle East and Africa (EMEA) and also has a presence in North America, Asia Pacific, and Latin America.
Contact Information
Website
www.medartis.comCorporate Office
- Hochbergerstrasse 60 East
- 4057 Basel
- Switzerland
Corporate Office
- Hochbergerstrasse 60 East
- 4057 Basel
- Switzerland
Medartis Stock Performance
As of 20-Nov-2026, Medartis’s stock price is $135.25. Its current market cap is $1.68B with 12.4M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $135.25 | $136.09 | $87.18 - $136.91 | $1.68B | 12.4M | 14.6K | $1.51 |
Medartis Financials Summary
As of 30-Jun-2026, Medartis has a trailing 12-month revenue of $387M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,430,081 | 1,392,357 | 846,335 | 1,245,398 |
| Revenue | 386,901 | 323,973 | 255,342 | 235,845 |
| EBITDA | 64,303 | 53,427 | 32,774 | 27,862 |
| Net Income | 18,804 | 10,046 | 4,007 | 689 |
| Total Assets | 755,134 | 707,044 | 509,071 | 416,142 |
| Total Debt | 256,552 | 199,162 | 133,669 | 32,055 |
Medartis Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Medartis Comparisons
Industry
Financing
Details
Medartis Competitors (4)
One of Medartis’s 4 competitors is Integra LifeSciences Holdings, a Corporation company based in Princeton, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Integra LifeSciences Holdings | Corporation | Princeton, NJ | ||||
| Shoulder Innovations | Venture Capital-Backed | Holland, MI | ||||
| Orthofix Medical | Formerly PE-Backed | Lewisville, TX | ||||
| Zimmer Biomet Holdings | Corporation | Warsaw, IN |
Medartis Patents
Medartis Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4792760-A1 | Bone plate and system for treating a fracture of a cavicula and/or tears of coracco-clavicular, coracco-acromial, and/or acromio-clavicular tapes | Pending | 12-Feb-2025 | ||
| WO-2026171393-A1 | Bone plate, system, and method for treating a fracture of the clavicle and/or tears of the coracoclavicular, coracoacromial, and/or acromioclavicular ligaments | Pending | 12-Feb-2025 | ||
| US-20250082378-A1 | Fibular nail outrigger surgical device | Pending | 13-Sep-2023 | ||
| US-20240293118-A1 | Compression fastener, instruments and methods | Inactive | 02-Mar-2023 | ||
| US-12496108-B2 | Orthopedic fasteners, instruments and methods | Active | 30-Dec-2022 | A61B17/8052 |
Medartis Signals
Medartis Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Medartis Investments & Acquisitions (10)
Medartis’s most recent deal was a Merger/Acquisition with Miami Anatomical Research Center. The deal was made on 17-Sep-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Miami Anatomical Research Center | 17-Sep-2026 | Merger/Acquisition | Other Healthcare Services | ||
| CADskills | 14-May-2026 | Merger/Acquisition | Therapeutic Devices | ||
| KeriMedical | 11-Jul-2025 | Merger/Acquisition | Therapeutic Devices | ||
| Neoortho | 29-Apr-2025 | Merger/Acquisition | Surgical Devices | ||
| In2Bones (Avenger Radial Head Prosthesis System in Memphis, Tennessee) | 27-Mar-2025 | Corporate Asset Purchase | Buildings and Property |
Medartis ESG
Risk Overview
Risk Rating
Updated November, 08, 2026
26.07 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
Medartis Affiliates
Subsidiaries (4)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| CADskills | Gent, Belgium | 2016 | |
| KeriMedical | Plan-les-Ouates, Switzerland | 2016 | |
| Miami Anatomical Research Center | Doral, FL | 2008 | |
| Neoortho | Curitiba, Brazil | 2004 |
Medartis FAQs
-
When was Medartis founded?
Medartis was founded in 1997.
-
Where is Medartis headquartered?
Medartis is headquartered in Basel, Switzerland.
-
What is the size of Medartis?
Medartis has 1,428 total employees.
-
What industry is Medartis in?
Medartis’s primary industry is Therapeutic Devices.
-
Is Medartis a private or public company?
Medartis is a Public company.
-
What is Medartis’s stock symbol?
The ticker symbol for Medartis is MED.
-
What is the current stock price of Medartis?
As of 20-Nov-2026 the stock price of Medartis is $135.25.
-
What is the current market cap of Medartis?
The current market capitalization of Medartis is $1.68B.
-
What is Medartis’s current revenue?
The trailing twelve month revenue for Medartis is $387M.
-
Who are Medartis’s competitors?
Integra LifeSciences Holdings, Shoulder Innovations, Orthofix Medical, and Zimmer Biomet Holdings are competitors of Medartis.
-
What is Medartis’s annual earnings per share (EPS)?
Medartis’s EPS for 12 months was $1.51.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process